Nevro Corp. develops and offers solutions for chronic pain management through its HFX therapy technology, which includes FDA-approved devices and AI-based recommendations for pain relief.

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

COM:NEVRO

Nevro Corp.

Last Close

4.23

21/11 21:00

Market Cap

294.20M

Beta: -

Volume Today

422.78K

Avg: -

locale

market

industry

website

ipo date

competitor of

Metrics